Interview 20 Mar 2025 AI meets biotech: Bullfrog AI’s CEO on the TechBio boom Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO. March 20, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2025 Breast cancer treatments heat up: Five therapies poised to transform patient outcomes Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches. March 19, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field. March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Mar 2025 How biotechs are using AI to rescue failed drugs Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs. March 17, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2025 Can GLP-1 agonists help treat addiction? Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders. March 14, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 14 Mar 2025Fighting Alzheimer’s with innovative stem cell therapies This week, we talk with Christopher Duma about his career in neurosurgery, the impetus for launching his biotech, and the promise of stem cell therapy in Alzheimer’s. March 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large. March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025 Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field. March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2025 The gender gap in clinical trials: Why women are still underrepresented Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it. March 11, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2025 23andMe: the collapse of a genomics giant 23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold? March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2025 Catalonia: A biotech hub going from strength to strength, with Barcelona at its core Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success. March 7, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 7 Mar 2025[Rebroadcast] How AI immune system mapping can boost drug discovery Learn about the data gap in drug discovery and how machine learning (ML) can solve it in our talk with Noam Solomon, CEO and co-founder of Immunai. March 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More